In Vitro Fertilization Market Estimates & Strategy Framework To 2022 - 2030

The global in vitro fertilization market size is expected to reach USD 37.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2022 to 2030. The market is driven by the continuous efforts of the market players, government initiatives to make available better reimbursement policies, and an increase in the incidence of infertility due to lifestyle changes. Expansion of fertility procedures such as ICSI for treating infertility is expected to positively impact the market growth in the near future.

In Vitro Fertilization Market Segmentation

Grand View Research has segmented the global in vitro fertilization market based on instrument, procedure type, end-use, and region:

Based on the Instruments Insights, the market is segmented into Disposable Devices, Culture Media and Capital Equipment.

• As industry players are introducing disposable devices, such as needles, slides, and chambers, to meet the sterility and regulatory requirements, the disposable devices segment is expected to likely witness the fastest growth rate during the forecast years.
• The culture media segment dominated the market for IVF and accounted for a revenue share of more than 41.0% in 2021.
• In May 2017, CrossBay Medical Inc. received U.S. FDA approval for its CrossBay IVF Embryo Transfer catheter set. The product has also received commercialization approval in Europe and China.

Based on the Procedure Type Insights, the market is segmented into Fresh Donor, Frozen Donor, Fresh Non-donor and Frozen Non-donor.

• The frozen non-donor segment led the market IVF and accounted for the largest revenue share of 47.0% in 2021.
• Certain factors contributing to the high share are the cost-effectiveness as compared to fresh non-donor and the less-invasive nature of the procedure.
• The shared donor egg program allows single donors to donate eggs to more than one recipient, without compromising the fertility rate.

Based on the End-Use Insights, the market is segmented into Fertility Clinics, Hospitals, and Other Setting.

• The fertility clinics segment dominated the market for IVF and accounted for the largest revenue share of more than 79.0% in 2021. The segment is likely to witness the fastest CAGR from 2022 to 2030.
• Factors, such as cost-effectiveness, availability of specialists, and minimal or no chances of Hospital-acquired Infections (HAIs), are anticipated to drive the growth of fertility clinics. IVF treatments are also performed in hospitals.
• The IVF treatments offered by hospitals are generally more expensive than fertility clinics. IVF treatments require highly skilled physicians and staff.

In Vitro Fertilization Regional Outlook.

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa (MEA)

Key Companies Profile & Market Share Insights

Geographical expansions, mergers, product innovations, and commercialization are the key strategies adopted by the market players. For instance, in July 2019, Vitrolife and Prime Tech entered into a collaboration agreement to design and market the Piezo technique for better Intracytoplasmic Sperm Injection (ICSI) procedure in human IVF globally except for Thailand, Japan, and Malaysia.

Some of the prominent players in the in vitro fertilization market include:

OvaScience

EMD Serono Inc.

Vitrolife AB

Irvine Scientific

Cook Medical Inc

Cooper Surgical Inc.

Genea Biomedx

Thermo Fisher Scientific Inc.

Progyny, Inc.

Boston IVF

Order a free sample PDF of the in vitro fertilization Market Intelligence Study, published by Grand View Research.